DGX

Quest Diagnostics Incorporated ·NYSE·Healthcare
237.93 live · 2026-08-12 15:59
46.0%
Brown Bear Score
43.2%
Business Conviction Score
56.5%
Position Health Score
47.2%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +33.1% · range 173.49–238.50

The Businesswhat the company reports

Business & cash flow

FCF / assets 8.4%
OCF / assets 11.6%
FCF / revenue 17.1%
Gross margin 33.2%
ROIC 11.4%
Forward P/E 19.7

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Price has run ahead of forward EPS growth by 5.3pp

Confidence 95.0/100

Takeaway Price and forward earnings growth are broadly in step; no strong valuation lean either way.

Reported earnings

Next report 2026-10-19 before the open · consensus EPS 2.88

Q3 23 revenue: 2.29bnQ3 23 net income: 225.00mQ3 23 EPS: 1.97Q4 23 revenue: 2.29bnQ4 23 net income: 192.00mQ4 23 EPS: 1.70Q4 23Q1 24 revenue: 2.37bnQ1 24 net income: 194.00mQ1 24 EPS: 1.73Q2 24 revenue: 2.40bnQ2 24 net income: 229.00mQ2 24 EPS: 2.04Q2 24Q3 24 revenue: 2.49bnQ3 24 net income: 226.00mQ3 24 EPS: 2.00Q4 24 revenue: 2.62bnQ4 24 net income: 222.00mQ4 24 EPS: 1.96Q4 24Q1 25 revenue: 2.65bnQ1 25 net income: 220.00mQ1 25 EPS: 1.95Q2 25 revenue: 2.76bnQ2 25 net income: 282.00mQ2 25 EPS: 2.50Q2 25Q3 25 revenue: 2.82bnQ3 25 net income: 245.00mQ3 25 EPS: 2.17Q4 25 revenue: 2.81bnQ4 25 net income: 245.00mQ4 25 EPS: 2.17Q4 25Q1 26 revenue: 2.90bnQ1 26 net income: 252.00mQ1 26 EPS: 2.25Q2 26 revenue: 3.04bnQ2 26 net income: 320.00mQ2 26 EPS: 2.86Q2 26

Revenue Net incomeEPS (GAAP) (1.70–2.86, own scale) Derived Q4

12 quarters to Q2 26. Revenue and net income share one scale, so the gap between them is the margin. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-06-30 3.04bn +10.2% 320.00m 2.86 3.12 +9.3% 2026-07-23
2026-03-31 2.90bn +9.2% 252.00m 2.25 2.50 +5.5% 2026-04-22
2025-12-31 (derived) 2.81bn +7.1% 245.00m 2.17 2.42 +1.5% 2026-02-26
2025-09-30 2.82bn +13.2% 245.00m 2.17 2.60 +2.8% 2025-10-21

Earnings response

Typical move around a filing ±2.5%
On an ordinary two days ±1.0% — filings move it 2.5× as much
Direction 6 up, 6 down over 12 filings
Revenue change and price reaction, by quarter
Q3 22 revenue -10.4% year on yearQ3 22 filed 2022-10-21: price +3.2%Q1 23 revenue -10.7% year on yearQ1 23 filed 2023-04-28: price -1.1%Q1 23Q2 23 revenue -4.7% year on yearQ2 23 filed 2023-07-27: price -1.3%Q3 23 revenue -7.7% year on yearQ3 23 filed 2023-10-25: price +6.2%Q3 23Q1 24 revenue +1.5% year on yearQ1 24 filed 2024-04-24: price -0.9%Q2 24 revenue +2.5% year on yearQ2 24 filed 2024-07-24: price +2.3%Q2 24Q3 24 revenue +8.4% year on yearQ3 24 filed 2024-10-23: price +0.3%Q1 25 revenue +12.1% year on yearQ1 25 filed 2025-04-23: price +1.8%Q1 25Q2 25 revenue +15.2% year on yearQ2 25 filed 2025-07-23: price -3.6%Q3 25 revenue +13.2% year on yearQ3 25 filed 2025-10-21: price -4.9%Q3 25Q1 26 revenue +9.2% year on yearQ1 26 filed 2026-04-22: price -2.7%Q2 26 revenue +10.2% year on yearQ2 26 filed 2026-07-23: price +8.6%Q2 26

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-06-30 2026-07-23 +10.2% +8.6%
2026-03-31 2026-04-22 +9.2% -2.7% -7.7%
2025-09-30 2025-10-21 +13.2% -4.9% +3.4%
2025-06-30 2025-07-23 +15.2% -3.6% +6.7%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Flat — little net change
Diluted shares 112.0M as at 2026-06-30
Change over 1 year -0.9%
Change over 3 years -1.8%
Public float $20.00bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 222.74 — 238.96
Protective stop 218.32 (Atr, 5.4% risk)
Support 229.38 (2 touches, 3.7% away)
Resistance 238.96 (0.5% away)

Takeaway The shares are nearer the ceiling than the floor: about 0.5% below 238.96, where sellers have turned up before, and 3.7% above 229.38, where buyers have stepped in before. That floor has held 2 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 5.4% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice ABOVE the cloud | periods 8/22/45 (86% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BULL
Cloud thickness100% percentile (thick — substantial structure)
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading above its cloud — a shaded band drawn from several of its own moving averages, currently 216.48 to 231.90. Being above it means the medium-term picture is pointing upwards, and that band is the first place the stock has recent support if it slips back. Its shorter-term averages agree with that. The band is unusually wide at the moment, so it marks a broad zone rather than a single level.

Trailing returns

21 days +15.4%
63 days +25.0%
126 days +15.8%
252 days +33.3%
Below 252d high0.3%

Trend context

PositionFar above trend
ExtensionExtremely extended
Trend slopeRising
Direction of travelHolding its deviation

Takeaway Extreme upside extension above Kalman fair trend; entry risk is elevated.

Volatility

State No recent compression
Current band width20.7% of price
Recent tightest20.7% (0 sessions ago, narrower than 10.0% of its history)
Expansion since1.00×
Band 204.52 — 251.65

Takeaway Lately this share price has been swinging around inside a range roughly 21% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 201.77–238.502026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

DGX: no binary-event flag. Near IV 26%, far IV 27% (ratio 0.95), implied move 3.2%.

Implied volatility 26% near (9d) · 27% far (100d)
Term structure 0.95× near/far
Historical volatility 34%
Implied vs historical 0.75×
Implied move ±3.2% by 2026-08-21
Implied move vs ATR 0.51×
Skew Put Skew (1.28×)
Call wall 240.00 (+0.9% away)
Put wall 210.00 (-11.7% away)
Gamma pin 210.00

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 3.2% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Mixed Rotation Phase

Rotation health 38.2/100; Negative Rotation.

Rotation health 38.2
Rotation strength 90.0
LegQuadrantRS-RatioRS-Mom
Stock vs sector Weakening 107.9 76.1
Stock vs SPY Weakening 103.3 77.9
Sector vs SPY Improving 86.4 102.1

Direction of travel: South-West / deteriorating rotation

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 6/9 (+8.0)
  • Altman Z-score 5.55 (+5.0)
  • Insider conviction score (+5.0)
  • Gross margin quality: 33.2% (+1.3)
  • ROIC quality: 11.4% (+1.8)
  • FCF margin quality: 17.1% (+5.1)
  • FCF margin improving by 3.6 pts (+1.0)
  • High earnings quality (accrual ratio -0.055) (+2.0)
  • Accrual ratio improving (-0.03 -> -0.06) (+2.0)
  • Relative Strength 9.4% vs sector: OUTPERFORMING (+10.0)
  • Track 2: MACD line/signal trend quality (+10.0)
  • Track 2: positive MACD trend regime (+10.0)
  • Track 2: relative strength trend improving (+10.0)
  • Track 2: 20-day momentum acceleration 0.18 (+16.0)
  • Track 2: bullish DI spread 6.3 (+3.0)
  • Track 2: ADX 54.4 and rising (+18.0)
  • Track 2: relative momentum rank 0.71 (+6.9)
  • Track 2: price above EMA20 by 3.7% (+3.1)
  • Track 2: EMA20 slope expanding 2.5% (+6.7)
  • Track 2: VPT strength 0.07 (+1.8)
  • Track 2: price above EMA50 by 9.3% (+7.4)
  • Track 2: EMA50 slope improving 4.4% (+6.0)
  • Track 2: Bollinger position 0.71 (+5.6)

Negative signals

  • Track 2: weak volume for momentum setup (0.49x average)
  • Track 2: Bearish MACD divergence
  • Track 2: MACD histogram deteriorating (-1.04)
  • Track 2: RSI deterioration/overheating 74.8, 5-day change -6.6
  • Chase risk 47.2/100 (Elevated Chase Risk): RSI 74.8, EMA20 3.7%, EMA50 9.3%, BB 0.71, distribution 24.1/100
  • Chase risk 47.2/100 | Extension score 52.8/100 | Elevated Chase Risk